Loading clinical trials...
Loading clinical trials...
This is a follow-up study to assess safety and preliminary clinical activity of ADR-001 in patients with liver cirrhosis (Child-Pugh score; Grade B) caused by Hepatitis C or Nonalcoholic Steatohepatit...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rohto Pharmaceutical Co., Ltd.
NCT06212635 · Hemostasis in Decompensated Liver Cirrhosis, Inflammation in Decompensated Liver Cirrhosis
NCT07002827 · Decompensated Liver Cirrhosis
NCT06723275 · Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, and more
NCT05871463 · Decompensated Liver Cirrhosis
NCT03945487 · Decompensated Liver Cirrhosis
Niigata University Medical & Dental Hospital
Niigata
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions